The "urban myth" of the association between neurological disorders and vaccinations [0.03%]
关于神经性疾病与疫苗关联的“都市神话”
R Gasparini,D Panatto,P L Lai et al.
R Gasparini et al.
In modern society, a potentially serious adverse event attributed to a vaccination is likely to be snapped up by the media, particularly newspapers and television, as it appeals to the emotions of the public. The widespread news of the alle...
Methodological criticisms in the evaluation of Pneumococcal Conjugate Vaccine effectiveness [0.03%]
肺炎链球菌结合疫苗有效性评估中的方法学批评
C Trucchi,C Paganino,F Ansaldi
C Trucchi
Globally, lower respiratory tract infections (LRTIs), including community-acquired pneumonia (CAP), cause considerable of morbidity and mortality in adults, especially in the elderly. In addition to age, underlying medical conditions are as...
A Bianchi,S Fantoni,A Prugnola
A Bianchi
A century of traditional vaccinology lost the fight against meningococcus serogroup B (MenB). However, thanks to an innovative genome-based approach, the first broadly effective MenB vaccine, Bexsero® (GSK Vaccines), was developed and has ...
Meningococcal B vaccination strategies and their practical application in Italy [0.03%]
意大利的脑膜炎球菌B疫苗策略及其实际应用
R Gasparini,D Amicizia,P L Lai et al.
R Gasparini et al.
Immunisation against meningococcal meningitis has a long history, which has passed through several phases: the studies by Flexner, extraction of the polysaccharide capsule, the development of monovalent and multivalent conjugate vaccines, t...
Meningococcal serogroup B vaccine in Italy: state-of-art, organizational aspects and perspectives [0.03%]
意大利的脑膜炎球菌B型疫苗：现状、组织方面和前景展望
C Signorelli,V Chiesa,A Odone
C Signorelli
Neisseria meningitidis causes severe invasive meningococcal diseases (IMDs) in humans including meningitis and septicemia, responsible for serious clinical conditions and leading to life-long disabilities and death. Serogroup B dominates IM...
Meningococcal disease in childhood: epidemiology, clinical features and prevention [0.03%]
儿童脑膜炎双球菌病：流行病学、临床表现和预防措施
S Bosis,A Mayer,S Esposito
S Bosis
Invasive meningococcal disease (IMD) represents a public health problem and a leading cause of morbidity and mortality worldwide. IMD can occur as an endemic disease with sporadic cases or epidemics with outbreaks. Neisseria meningitis stra...
Epidemiology of Neisseria meningitidis infections: case distribution by age and relevance of carriage [0.03%]
流行性脑膜炎双球菌感染的流行病学：各年龄组病例分布及带菌的相关性
G Gabutti,A Stefanati,P Kuhdari
G Gabutti
Notwithstanding different meningococcal serogroups have changed their distribution and their impact in different age classes over time, N. meningitidis' invasive diseases are a major public health issue worldwide, due to the related complic...
Estimates of the burden of meningococcal disease in Italy: implications for prevention and control [0.03%]
意大利脑膜炎双球菌疾病负担的估计情况及其对预防和控制的意义
D Martinelli,F Fortunato,R Prato
D Martinelli
Meningococcal disease is an acute, severe bacterial infection caused by Neisseria meningitidis. The most common presentations of invasive meningococcal infection (IMD) are meningitis and sepsis, less common pathologic presentations include ...
Logistic regression of attitudes and coverage for influenza vaccination among Italian Public Health medical residents [0.03%]
意大利公共卫生内科住院医的流感疫苗态度与接种情况的逻辑回归分析
V Di Gregori,G Franchino,C Marcantoni et al.
V Di Gregori et al.
Introduction: A few number of literature specifically addresses vaccination uptake among Public Health Residents (PHRs). Influenza vaccine attitudes and risk perceptions of PHRs across Italy were studied, contributing to ...
Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012 [0.03%]
2005-2012年托斯卡纳脑膜炎球菌C结合疫苗接种后事件的监测
M Levi,M Donzellini,O Varone et al.
M Levi et al.
Introduction: Post-licensure vaccine safety studies are essential to identify uncommon events that may be difficult to assess during pre-licensure studies. The aim of our study was to evaluate the safety of serogroup C me...